(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

CENTRE FOR ONCOLOGY AND IMMUNOLOGY

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: CombinedOffice: United States

Quick snapshot

CENTRE FOR ONCOLOGY AND IMMUNOLOGY

ST13

US500000098870149

Class

9, 42

Filing

98870149

Registration

7990817

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

20

Latest update

10/22/2025

Trademark type

Combined

Nice classes

9, 42

Filing date

11/24/2024

Registration date

10/21/2025

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

10/21/2025

Last transaction

10/22/2025

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Filing basis

Foreign priority

Drawing code

3

Owner type

99

Owner location

PAK SHEK KOK, NT, HK

Examiner

WRIGHT,MARCO JABBAR

Current location

FILE REPOSITORY (FRANCONIA)

Mark description

The mark consists of a logo on the left side, featuring a solid circular design with a hollow center and a horizontal line extending from the center toward the right side of the circle. To the right of the logo is the text "CENTRE FOR ONCOLOGY AND IMMUNOLOGY" in bold font, with Chinese characters beneath the English text.

Holders and representatives

Holders

Centre for Oncology and Immunology Limited

Representatives

Elias Hantula

Technical classification

Nice Classes

Class 9Class 42

Vienna Codes

No Vienna codes available.

Goods and services

Class 9

Bioreactors for cell culturing for scientific research; Bioreactors for laboratory use; Data processing apparatus; Diagnostic apparatus for research laboratory use for screening organ tissue-derived panelsbiopsiesmodelsconducting protein assaysanalyzing nucleotide expression levelstracking organelle behavior for oncology and immunology research in the fields of geneticscell biologyoncologyimmunology research; Downloadable computer software platforms for integrating and processing datasets and image setsaccessing controls and utilizing derived embeddingsconducting exploratoryconfirmatorymodeling analysis for laboratory use in the fields of geneticscell biologyoncologyimmunology; Recorded computer software platforms for integrating and processing datasets and image setsaccessing controls and utilizing derived embeddingsconducting exploratoryconfirmatorymodeling analysis for research laboratory use in the fields of geneticscell biologyoncologyimmunology

Class 42

Research and development of new products for others; Bacteriological research; Biological research; Medical research services; Medical and scientific research in the field of cancer treatment and diagnosis; Scientific research; Scientific research in the nature of conducting clinical trials for others in the field of oncology and immunology research; Technological research in the field of oncology and immunology

Publications

History of USPTO decisions and trademark events.

20 publications found

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

10/21/2025

R.PR

REGISTERED-PRINCIPAL REGISTER

10/21/2025

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

09/02/2025

PUBO

PUBLISHED FOR OPPOSITION

09/02/2025

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

08/27/2025

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

07/30/2025

XAEC

EXAMINER'S AMENDMENT ENTERED

07/30/2025

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

07/30/2025

GNEA

EXAMINERS AMENDMENT E-MAILED

07/30/2025

CNEA

EXAMINERS AMENDMENT -WRITTEN

07/30/2025

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

07/16/2025

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

07/15/2025

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

07/15/2025

GNRN

NOTIFICATION OF NON-FINAL ACTION E-MAILED

05/19/2025

GNRT

NON-FINAL ACTION E-MAILED

05/19/2025

CNRT

NON-FINAL ACTION WRITTEN

05/19/2025

DOCK

ASSIGNED TO EXAMINER

05/16/2025

MDSC

NOTICE OF DESIGN SEARCH CODE E-MAILED

05/13/2025

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/13/2025

NWAP

NEW APPLICATION ENTERED

11/25/2024

Continuous trademark protection

Get notified about every new filing that threatens CENTRE FOR ONCOLOGY AND IMMUNOLOGY or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.